Brent Tadayoshi Shoji, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Splenic Diseases | 1 | 2009 | 90 | 0.310 |
Why?
|
| Gastric Fistula | 1 | 2009 | 73 | 0.310 |
Why?
|
| Fistula | 1 | 2009 | 212 | 0.290 |
Why?
|
| Splenectomy | 2 | 2019 | 391 | 0.280 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2023 | 168 | 0.190 |
Why?
|
| Hodgkin Disease | 1 | 2009 | 1378 | 0.190 |
Why?
|
| Hunger | 1 | 2022 | 206 | 0.180 |
Why?
|
| Splenomegaly | 1 | 2018 | 189 | 0.150 |
Why?
|
| Hernia, Ventral | 1 | 2020 | 218 | 0.130 |
Why?
|
| Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
| Rectal Diseases | 1 | 1994 | 143 | 0.100 |
Why?
|
| Colonic Diseases | 1 | 1994 | 201 | 0.100 |
Why?
|
| Overweight | 1 | 2022 | 2412 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 1303 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11735 | 0.080 |
Why?
|
| Leukemia | 1 | 2016 | 1523 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 3590 | 0.070 |
Why?
|
| Lymphoma | 1 | 2016 | 1901 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2018 | 2035 | 0.070 |
Why?
|
| Chewing Gum | 1 | 2006 | 40 | 0.070 |
Why?
|
| Ileus | 1 | 2006 | 66 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5303 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2009 | 1833 | 0.060 |
Why?
|
| Colectomy | 2 | 2006 | 688 | 0.050 |
Why?
|
| Receptors, CCR7 | 1 | 2023 | 107 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2020 | 12949 | 0.050 |
Why?
|
| Sigmoid Neoplasms | 1 | 2001 | 54 | 0.050 |
Why?
|
| Ghrelin | 1 | 2022 | 252 | 0.050 |
Why?
|
| Appetite | 1 | 2022 | 247 | 0.040 |
Why?
|
| Intestinal Obstruction | 2 | 1994 | 432 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 687 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 13333 | 0.040 |
Why?
|
| Tyrosine | 1 | 2022 | 1438 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2022 | 787 | 0.040 |
Why?
|
| Endosonography | 1 | 2001 | 610 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 2001 | 525 | 0.030 |
Why?
|
| Leukemia, Experimental | 1 | 2016 | 225 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1624 | 0.030 |
Why?
|
| Eating | 1 | 2022 | 1537 | 0.030 |
Why?
|
| Rectal Neoplasms | 2 | 1994 | 1157 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2009 | 12972 | 0.030 |
Why?
|
| Energy Intake | 1 | 2022 | 2134 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 1959 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2016 | 352 | 0.030 |
Why?
|
| Leptin | 1 | 2022 | 1595 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2018 | 636 | 0.030 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 226 | 0.030 |
Why?
|
| Colitis, Ischemic | 1 | 1994 | 32 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2023 | 2423 | 0.030 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1994 | 92 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 2859 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 367 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2016 | 712 | 0.030 |
Why?
|
| Organ Size | 1 | 2018 | 2252 | 0.030 |
Why?
|
| Diverticulitis, Colonic | 1 | 1994 | 138 | 0.030 |
Why?
|
| Gastrointestinal Motility | 1 | 1994 | 234 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 2014 | 0.030 |
Why?
|
| Thromboembolism | 1 | 2018 | 996 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2016 | 1825 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2389 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2022 | 2879 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2023 | 3543 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 3873 | 0.020 |
Why?
|
| Middle Aged | 6 | 2020 | 220774 | 0.020 |
Why?
|
| Constipation | 1 | 1994 | 562 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 1525 | 0.020 |
Why?
|
| Reoperation | 1 | 2018 | 4302 | 0.020 |
Why?
|
| Humans | 11 | 2023 | 761326 | 0.020 |
Why?
|
| Aged | 6 | 2020 | 169179 | 0.020 |
Why?
|
| Recurrence | 1 | 2020 | 8470 | 0.020 |
Why?
|
| Male | 6 | 2020 | 360621 | 0.020 |
Why?
|
| Appendicitis | 1 | 1994 | 675 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2016 | 2556 | 0.020 |
Why?
|
| Adult | 5 | 2022 | 221122 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2023 | 5665 | 0.020 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 1994 | 1116 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2023 | 16966 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2019 | 58946 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2020 | 80575 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1863 | 0.020 |
Why?
|
| Piperazines | 1 | 2016 | 2519 | 0.020 |
Why?
|
| Length of Stay | 1 | 2018 | 6422 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2811 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2018 | 3267 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3611 | 0.010 |
Why?
|
| Internet | 1 | 2016 | 3094 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2006 | 15647 | 0.010 |
Why?
|
| Mice | 2 | 2023 | 81474 | 0.010 |
Why?
|
| Female | 7 | 2020 | 392485 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1994 | 2534 | 0.010 |
Why?
|
| Placebos | 1 | 2006 | 1667 | 0.010 |
Why?
|
| Photomicrography | 1 | 2001 | 71 | 0.010 |
Why?
|
| Sigmoidoscopy | 1 | 2001 | 151 | 0.010 |
Why?
|
| Thrombosis | 1 | 1994 | 2942 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 12934 | 0.010 |
Why?
|
| Research Design | 1 | 2016 | 6178 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9414 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 3419 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2018 | 64645 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1994 | 2421 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10203 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16603 | 0.010 |
Why?
|
| Animals | 2 | 2023 | 168388 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2006 | 6231 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2001 | 1626 | 0.010 |
Why?
|
| Adolescent | 2 | 2019 | 88305 | 0.010 |
Why?
|
| Intestine, Large | 1 | 1994 | 68 | 0.010 |
Why?
|
| Mesenteric Veins | 1 | 1994 | 86 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13635 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 74152 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 59196 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2006 | 54405 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2001 | 39108 | 0.000 |
Why?
|